UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women

Not Applicable

Not yet recruiting

Conditions: Resistance Training
Overweight or Obesity
Prediabetes or Diabetes
Prehypertension (Elevated Blood Pressure) or Hypertension

Interventions: Behavioral: Resistance Training

First Posted Date: 2024-04-11

Last Posted Date: 2024-08-01

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 36

Registration Number: NCT06360536

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Adapting Enhanced Recovery Programs for Low Health Literacy Patients

Not Applicable

Not yet recruiting

Conditions: Health Knowledge, Attitudes, Practice
Surgery
Colorectal Disorders

Interventions: Other: Educational intervention (VISACT)

First Posted Date: 2024-04-10

Last Posted Date: 2024-04-10

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 1050

Registration Number: NCT06356558

A Community Health Worker Intervention to Address Adverse Pregnancy Outcomes

Not Applicable

Not yet recruiting

Conditions: Preeclampsia Postpartum
Adverse Pregnancy Outcomes

Interventions: Behavioral: usual postpartum care + community health worker intervention
Behavioral: usual postpartum care

First Posted Date: 2024-04-09

Last Posted Date: 2024-07-05

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 60

Registration Number: NCT06353256

Locations: 🇺🇸
UAB Medicine, Birmingham, Alabama, United States
🇺🇸
The University of Alabama at Birmingham, Birmingham, Alabama, United States

Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants

Not Applicable

Recruiting

Conditions: Infant, Premature, Diseases
Child Development
Infant Development

Interventions: Behavioral: Finger puppet
Behavioral: Bookworm reading intervention training and routine EDI care.

First Posted Date: 2024-03-28

Last Posted Date: 2024-12-16

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 188

Registration Number: NCT06335524

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease

Not Applicable

Recruiting

Conditions: Urolithiasis
Nephrolithiasis, Calcium Oxalate
Urolithiasis, Calcium Oxalate
Nephrolithiasis
Kidney Calculi
Kidney Stone
Oxalate Urolithiasis
Oxaluria

Interventions: Dietary Supplement: Low oxalate fixed diets pre-colonization
Dietary Supplement: Moderately high oxalate fixed diets pre-colonization
Dietary Supplement: Colonization with Oxalobacter formigenes
Dietary Supplement: Low oxalate fixed diets post-colonization
Dietary Supplement: Moderately high oxalate fixed diets post-colonization

First Posted Date: 2024-03-26

Last Posted Date: 2024-05-08

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 40

Registration Number: NCT06330246

Locations: 🇺🇸
UTSW, Dallas, Texas, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Gut Oxalate Absorption in Calcium Oxalate Stone Disease

Not Applicable

Recruiting

Conditions: Kidney Calculi
Healthy
Urolithiasis
Urolithiasis, Calcium Oxalate
Nephrolithiasis
Nephrolithiasis, Calcium Oxalate
Kidney Stone
Oxalate Urolithiasis
Oxaluria

Interventions: Dietary Supplement: Low-oxalate diet
Dietary Supplement: High-oxalate diet
Other: soluble oxalate gut absorption test

First Posted Date: 2024-03-26

Last Posted Date: 2024-05-08

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 80

Registration Number: NCT06331546

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
UTSW, Dallas, Texas, United States

A Study to Demonstrate the Safety and Efficacy of Siplizumab in the Treatment of Hidradenitis Suppurativa

Early Phase 1

Not yet recruiting

Conditions: Hidradenitis Suppurativa

Interventions: Drug: Siplizumab

First Posted Date: 2024-03-22

Last Posted Date: 2024-03-22

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 12

Registration Number: NCT06326476

Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study

Recruiting

Conditions: Acute Myeloid Leukemia

First Posted Date: 2024-03-21

Last Posted Date: 2024-05-07

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 60

Registration Number: NCT06323590

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway

Phase 2

Not yet recruiting

Conditions: Insulin Sensitivity/Resistance
Metabolic Disease
Metabolism
Energy Expenditure
Cardiovascular Diseases
Obesity

Interventions: Drug: Vericiguat 10 MG
Other: Placebo
Other: Insulin Sensitivity Test
Other: Resting Energy and Exercise Energy Expenditure Assessment
Other: White Adipose Tissue Biopsy
Other: MRI-PET Scan for Brown Adipose Tissue Volume Assessment

First Posted Date: 2024-03-20

Last Posted Date: 2024-05-06

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 200

Registration Number: NCT06320951

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

Phase 2

Not yet recruiting

Conditions: GVHD,Acute
Acute Leukemia
Myelodysplastic Syndromes
Myeloproliferative Disorders

Interventions: Drug: ATG Combined with Tacrolimus and Mini Methotrexate

First Posted Date: 2024-03-18

Last Posted Date: 2024-12-04

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 29

Registration Number: NCT06315309

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Home Terms & Conditions Privacy Policy